Changes in choroidal blood flow during light/dark transitions are not altered by atropine or propranolol in healthy subjects

Gabriele Fuchsjäger-Mayrl, Magdalena Malec, Tina Amoako-Mensah, Julia Kolodjaschna, Leopold Schmetterer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Abstract

It has recently been reported that light/dark transitions lead to changes in choroidal blood flow. Several observations indicate that these changes in choroidal perfusion are triggered at least in part by neural mechanisms. In the present study we hypothesised that the choroidal blood flow response to changes in retinal illumination may be modified by either the muscarinic receptor antagonist atropine or by the β-receptor antagonist propranolol. In 15 healthy subjects the response of choroidal perfusion was studied in a randomised placebo-controlled three way cross-over study using laser Doppler flowmetry and laser interferometric measurement of fundus pulsation amplitude. Before drug administration a transition from light to dark reduced both choroidal haemodynamic parameters by 8%-12%. Neither propranolol nor atropine altered basal choroidal blood flow or choroidal blood flow responses to light/dark transitions. Our data indicate that neither muscarinic nor β-receptors are involved in the choroidal blood flow response to changes in retinal illumination. Further studies are required to elucidate which mechanisms contribute to this blood flow behaviour of the choroid.

Original languageEnglish
Pages (from-to)2185-2190
Number of pages6
JournalVision Research
Volume43
Issue number20
DOIs
Publication statusPublished - Sept 2003
Externally publishedYes

ASJC Scopus Subject Areas

  • Ophthalmology
  • Sensory Systems

Keywords

  • Choroidal blood flow
  • Human
  • Light/dark transitions
  • Neuronal mechanisms

Fingerprint

Dive into the research topics of 'Changes in choroidal blood flow during light/dark transitions are not altered by atropine or propranolol in healthy subjects'. Together they form a unique fingerprint.

Cite this